In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the ...

Anxiety and depression are more common among people with Crohn’s disease, and they can worsen symptoms. Here’s why and ways ...

Findings from this study are poised to have a remarkable impact on treatment for ulcerative colitis and IBD overall. The investigational therapy was generated based on the concept of precision ...

Widjaja Inflammatory Bowel Disease Institute at Cedars-Sinai. "The investigational therapy was generated based on the concept of precision medicine; it shows promise as being both anti ...

Ulcerative colitis is a chronic condition characterized ... approaches to help people who have not responded to conventional therapy. Study author Bruce E. Sands, MD, MS, with the Division of ...

In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis ...

Patients with inflammatory bowel disease (IBD) continue to experience barriers to health care access and treatment and financial struggles.

Analysts have suggested that TL1A inhibitors could have blockbuster sales potential as second-line therapy for IBD refractory to first-line TNF biologics, with plenty of upside if they move into ...

Biologic therapy intolerance vs failure is associated with improved treatment outcomes among patients with inflammatory bowel diseases.